CID 11626560

Crizotinib

Structural Information

Molecular Formula
C21H22Cl2FN5O
SMILES
C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N
InChI
InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1
InChIKey
KTEIFNKAUNYNJU-GFCCVEGCSA-N
Compound name
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
Related CIDs

2D Structure

compound 2d structure
7
Annotation Hits

2075
References

35945
Patents

449.11853 Da
Monoisotopic Mass

3.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 450.12581 203.6
[M+Na]+ 472.10775 211.1
[M-H]- 448.11125 207.1
[M+NH4]+ 467.15235 208.7
[M+K]+ 488.08169 201.8
[M+H-H2O]+ 432.11579 190.6
[M+HCOO]- 494.11673 206.4
[M+CH3COO]- 508.13238 209.6
[M+Na-2H]- 470.09320 198.9
[M]+ 449.11798 201.0
[M]- 449.11908 201.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe